Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria

Infection and Immunity

Volumn 76, Issue 4, 2008, Pages 1719-1727

  Esin, Semih ^a   Batoni, Giovanna ^a   Counoupas, Claudio ^a   Stringaro, Annarita ^b   Brancatisano, Franca Lisa ^a   Colone, Marisa ^b   Maisetta, Giuseppantonio ^a   Florio, Walter ^a   Arancia, Giuseppe ^b   Campa, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD56 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NATURAL KILLER CELL RECEPTOR; PHYCOERYTHRIN; PROTEIN NKP30; PROTEIN NKP44; PROTEIN NKP46; UNCLASSIFIED DRUG; FC RECEPTOR; IMMUNOGLOBULIN RECEPTOR; NCR1 PROTEIN, HUMAN; NCR2 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVATION; CHIMERA; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; MYCOBACTERIUM; NATURAL KILLER CELL; NOCARDIA FARCINICA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; TRANSMISSION ELECTRON MICROSCOPY; BACTERIUM; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN BINDING;

ANTIGENS, CD56; BACTERIA; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; PROTEIN BINDING; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC;

EID: 42149091828     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00870-07     Document Type: Article

References (28)

1. Arnon, T. I., M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680-2689.
2. Arnon, T. I., H. Achdout, O. Levi, G. Markel, N. Saleh, G. Katz, R. Gazit, T. Gonen-Gross, J. Hanna, E. Nahari, A. Porgador, A. Honigman, B. Plachter, D. Mevorach, D. G. Wolf, and O. Mandelboim. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6:515-523.
3. Barry, C. E., III, R. E. Lee, K. Mdluli, A. E. Sampson, B. G. Schroeder, R. A. Slayden, and Y. Yuan. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37:143-179.
4. Batoni, G., D. Bottai, G. Maisetta, M. Pardini, A. Boschi, W. Florio, S. Esin, and M. Campa. 2001. Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis. FEMS Microbiol. Lett. 205:125-129.
5. dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scand. J. Immunol. 62:498-506.
6. Batoni, G., S. Esin, M. Pardini, D. Bottai, S. Senesi, H. Wigzell, and M. Campa. 2000. Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille Calmette-Guerin (BCG). Clin. Exp. Immunol. 119:270-279.
7. Becker, I., N. Salaiza, M. Aguirre, J. Delgado, N. Carrillo-Carrasco, L. G. Kobeh, A. Ruiz, R. Cervantes, A. P. Torres, N. Cabrera, A. Gonzalez, C. Maldonado, and A. Isibasi. 2003. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Mol. Biochem. Parasitol. 130:65-74.
8. Bottino, C., R. Castriconi, L. Moretta, and A. Moretta. 2005. Cellular ligands of activating NK receptors. Trends Immunol. 26:221-226.
9. Boysen, P., S. Klevar, I. Olsen, and A. K. Storset. 2006. The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts. Infect. Immun. 74:953-960.
10. Chalifour, A., P. Jeannin, J. F. Gauchat, A. Blaecke, M. Malissard, T. N'Guyen, N. Thieblemont, and Y. Delneste. 2004. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104:1778-1783.
11. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
12. Delogu, G., C. Pusceddu, A. Bua, G. Fadda, M. J. Brennan, and S. Zanetti. 2004. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol. Microbiol. 52: 725-733.
13. Esin, S., G. Batoni, M. Pardini, F. Favilli, D. Bottai, G. Maisetta, W. Florio, R. Vanacore, H. Wigzell, and M. Campa. 2004. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guerin. Immunology 112:143-152.
14. Esin, S., G. Batoni, G. Kallenius, H. Gaines, M. Campa, S. B. Svenson, R. Andersson, and H. Wigzell. 1996. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium. Clin. Exp. Immunol. 104:419-425.
15. Garg, A., P. F. Barnes, A. Porgador, S. Roy, S. Wu, J. S. Nanda, D. E. Griffith, W. M. Girard, N. Rawal, S. Shetty, and R. Vankayalapati. 2006. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J. Immunol. 177:6192-6198.
16. Hershkovitz, O., S. Jivov, N. Bloushtain, A. Zilka, G. Landau, A. Bar-Ilan, R. G. Lichtenstein, K. S. Campbell, T. H. van Kuppevelt, and A. Porgador. 2007. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46:7426-7436.
17. Kikuchi-Maki, A., S. Yusa, T. L. Catina, and K. S. Campbell. 2003. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-γ production. J. Immunol. 171:3415-3425.
18. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as initial defense against pathogens. Curr. Opin. Immunol. 18:391-398.
19. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060.
20. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
21. Moretta, A., C. Bottino, M. C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3:6-8.
22. Moretta, L., and A. Moretta. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23:255-259.
23. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7:279-291.
24. Nylén, S., K. Maasho, K. Söderström, T. Ilg, and H. Akuffo. 2003. Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. Clin. Exp. Immunol. 131:457-467.
25. O'Connor, G. M., O. M. Hart, and C. M. Gardiner. 2005. Putting the natural killer cell in its place. Immunology 117:1-10.
26. bright cells in tuberculous pleurisy. J. Immunol. 175:6852-6860.
27. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175:4611-4617.
28. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065-2072.